PL2968227T3 - Wzbogacone s-enancjomerycznie kompozycje beta-blokerów do leczenia stwardnienia zanikowego bocznego - Google Patents

Wzbogacone s-enancjomerycznie kompozycje beta-blokerów do leczenia stwardnienia zanikowego bocznego

Info

Publication number
PL2968227T3
PL2968227T3 PL14764992T PL14764992T PL2968227T3 PL 2968227 T3 PL2968227 T3 PL 2968227T3 PL 14764992 T PL14764992 T PL 14764992T PL 14764992 T PL14764992 T PL 14764992T PL 2968227 T3 PL2968227 T3 PL 2968227T3
Authority
PL
Poland
Prior art keywords
lateral sclerosis
amyotrophic lateral
enantiomerically enriched
beta blockers
treating amyotrophic
Prior art date
Application number
PL14764992T
Other languages
English (en)
Inventor
Andrew J.S. COATS
Stefan Anker
Jochen Springer
Original Assignee
Andrew J.S. COATS
Charité - Universitätsmedizin Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew J.S. COATS, Charité - Universitätsmedizin Berlin filed Critical Andrew J.S. COATS
Publication of PL2968227T3 publication Critical patent/PL2968227T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14764992T 2013-03-14 2014-03-14 Wzbogacone s-enancjomerycznie kompozycje beta-blokerów do leczenia stwardnienia zanikowego bocznego PL2968227T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786235P 2013-03-14 2013-03-14
PCT/AU2014/000274 WO2014138814A1 (en) 2013-03-14 2014-03-14 S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
EP14764992.5A EP2968227B1 (en) 2013-03-14 2014-03-14 S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

Publications (1)

Publication Number Publication Date
PL2968227T3 true PL2968227T3 (pl) 2019-09-30

Family

ID=51535623

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14764992T PL2968227T3 (pl) 2013-03-14 2014-03-14 Wzbogacone s-enancjomerycznie kompozycje beta-blokerów do leczenia stwardnienia zanikowego bocznego

Country Status (11)

Country Link
US (3) US10449166B2 (pl)
EP (1) EP2968227B1 (pl)
CN (1) CN105358140A (pl)
AU (1) AU2014231724B2 (pl)
CA (1) CA2906206C (pl)
DK (1) DK2968227T3 (pl)
ES (1) ES2725893T3 (pl)
HK (1) HK1220609A1 (pl)
PL (1) PL2968227T3 (pl)
PT (1) PT2968227T (pl)
WO (1) WO2014138814A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3015313A1 (en) 2016-02-26 2017-08-31 Actimed Therapeutics Ltd S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
HUP1800298A1 (hu) * 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222231T1 (de) * 1996-09-18 2002-08-15 Daiso Co Ltd Verfahren zur herstellung von 3-amino-2-hydroxy-1-propylethern
US20050143378A1 (en) * 2003-12-29 2005-06-30 Yun Anthony J. Treatment of conditions through pharmacological modulation of the autonomic nervous system
US20070021421A1 (en) * 2005-07-25 2007-01-25 Hampton Thomas G Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis
CN101323580A (zh) * 2008-07-25 2008-12-17 河北科技大学 手性芳氧丙醇胺类化合物及其盐的合成方法
GB0907350D0 (en) * 2009-04-29 2009-06-10 Myotec Therapeutics Ltd Methods
JP2015526423A (ja) * 2012-07-25 2015-09-10 サイオクサス セラピューティクス リミテッド カヘキシア及びサルコペニアを治療するためのs−ピンドロールの使用

Also Published As

Publication number Publication date
US10449166B2 (en) 2019-10-22
US11938102B2 (en) 2024-03-26
US20200054585A1 (en) 2020-02-20
AU2014231724B2 (en) 2018-05-10
US11007158B2 (en) 2021-05-18
US20160022613A1 (en) 2016-01-28
NZ713051A (en) 2020-09-25
ES2725893T3 (es) 2019-09-30
CA2906206A1 (en) 2014-09-18
CN105358140A (zh) 2016-02-24
EP2968227A1 (en) 2016-01-20
CA2906206C (en) 2021-09-14
US20210330615A1 (en) 2021-10-28
EP2968227B1 (en) 2019-02-13
DK2968227T3 (da) 2019-05-13
PT2968227T (pt) 2019-05-30
AU2014231724A1 (en) 2015-10-29
EP2968227A4 (en) 2016-10-26
WO2014138814A1 (en) 2014-09-18
HK1220609A1 (zh) 2017-05-12

Similar Documents

Publication Publication Date Title
IL261725A (en) New preparations for the treatment of lateral column sclerosis in the spine
GB2544342B (en) Compositions for application to wounds
HK1258223A1 (zh) 用於治療肌萎縮性脊髓側索硬化症的新組合物
SG11201602596UA (en) Stabilized efinaconazole compositions
HK1214618A1 (zh) 含有透明質酸的穩定化組合物
EP2895606A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF AMYOTROPHER LATERAL SCLEROSIS (ALS)
PL3199613T3 (pl) Kompozycje oczyszczające
PL3021839T3 (pl) Kompozycje do leczenia zwłóknienia
EP2906580A4 (en) TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
PL3086751T3 (pl) Stabilizowane kompozycje cyny
GB2511350B (en) Skincare compositions
GB201320409D0 (en) Prebiotic composition
GB201305556D0 (en) Skincare compositions
PL3021840T3 (pl) Kompozycje do zapobiegania reakcji alergicznej
PT2964381T (pt) Composição para a produção de massas de borracha de silicone
EP2814479A4 (en) METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
HK1220609A1 (zh) 種用於治療肌萎縮性側索硬化症的β受體阻滯劑的 -對映體富集組合物
HRP20182110T1 (hr) Sastav spojeva tiakumicina
GB2515071B (en) Novel composition for a foot-soaking bath
HK1203406A1 (en) New compositions for treating amyotrophic lateral sclerosis
HK1204865A1 (en) Composition for elimination of troublesome varmints
SI2819664T1 (sl) Novi sestavki za zdravljenje amiotrofične lateralne skleroze
GB201315461D0 (en) Composition of phosphonates
ZA201401705B (en) Coating composition for application to new plasterwork
GB201303721D0 (en) Compositions for treatment of sleep disorders